Literature DB >> 6219171

Prednisone-induced alterations of circulating human lymphocyte subsets.

J D Slade, B Hepburn.   

Abstract

Peripheral lymphopenia occurs in man after administration of glucocorticoids. By using subset-specific monoclonal antibodies, the number of peripheral T cells (OKT11+) and the number of cells in the helper-inducer (OKT4+) and suppressor-cytotoxic (OKT8+) subsets were determined in four healthy subjects before and after ingestion of 20 mg of prednisone. In all subjects, the number of circulating T cells declined. The mean ratio of OKT4+ to OKT8+ cells dropped from 2.3 to 1.6 at 4 hr after prednisone ingestion and returned to baseline at 24 hr. The changed ratio was due to a disproportionate decrease in OKT4+ cells. A smaller decrease in the absolute number of circulating OKT8+ cells occurred, but the proportion of OKT8+ cells did not change. There was a direct relationship between prednisone dose and the reduction in circulating OKT4+ cells in the one subject who took four different doses of prednisone; there was a lymphopenic effect at the 5 mg dose. In vitro exposure of lymphocytes to methylprednisolone did not result in significant lympholysis or in alteration of the relative numbers of cells in the OKT4+ and OKT8+ subsets. The lymphopenia produced by prednisone in a splenectomized healthy subject was indistinguishable from that observed in nonsplenectomized subjects. The number of circulating B cells was unaffected by 20 mg of prednisone. These studies demonstrate that prednisone-induced lymphopenia involves the OKT4+ subset to a greater degree than the OKT8+ subset. The effect could not be accounted for by lympholysis or by redistribution of lymphocytes to the spleen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6219171

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  37 in total

1.  Association between memory B-cells and clinical and immunological features of primary Sjögren's syndrome and Sicca patients.

Authors:  Filipe Barcelos; Catarina Martins; Ana Papoila; Carlos Geraldes; Joana Cardigos; Glória Nunes; Teresa Lopes; Nuno Alves; José Vaz-Patto; Jaime Branco; Luís-Miguel Borrego
Journal:  Rheumatol Int       Date:  2018-04-06       Impact factor: 2.631

2.  Basis for defective proliferation of peripheral blood T cells to anti-CD2 antibodies in primary Sjögren's syndrome.

Authors:  R Gerli; A Bertotto; E Agea; L Lanfrancone; C Cernetti; F Spinozzi; P Rambotti
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

3.  Circulating CD4+CD8+ cells in myasthenia gravis: supplementary immunological parameter for long-term prognosis.

Authors:  M Matsui; H Fukuyama; I Akiguchi; M Kameyama
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

4.  Bronchoalveolar lavage.

Authors:  J Golden
Journal:  West J Med       Date:  1986-09

5.  Pneumocystis pneumonia in brain tumor patients: risk factors and clinical features.

Authors:  D Schiff
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

6.  Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations.

Authors:  Nadera J Sweiss; Rafah Salloum; Seema Gandhi; Seema Ghandi; Maria-Luisa Alegre; Ray Sawaqed; Maria Badaracco; Kenneth Pursell; David Pitrak; Robert P Baughman; David R Moller; Joe G N Garcia; Timothy B Niewold
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

7.  Cryptococcal osteomyelitis and meningitis in a patient with non-hodgkin's lymphoma treated with PEP-C.

Authors:  Christina A To; Robert W Hsieh; James Scott McClellan; Walter Howard; Nancy J Fischbein; Janice M Y Brown; Dean W Felsher; Alice C Fan
Journal:  BMJ Case Rep       Date:  2012-09-07

8.  Systemic immune response of patients with active pulmonary sarcoidosis.

Authors:  R P Baughman; P E Hurtubise
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

9.  Pharmacoimmunodynamics of methylprednisolone: trafficking of helper T lymphocytes.

Authors:  L E Fisher; E A Ludwig; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1992-08

10.  Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.

Authors:  L E Fisher; E A Ludwig; J A Wald; R R Sloan; E Middleton; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1992-06       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.